Department of Pediatrics, Vanderbilt University Medical Center, Nashville, TN, USA.
Vanderbilt University, Nashville, TN, USA.
BMC Neurol. 2023 Feb 3;23(1):57. doi: 10.1186/s12883-023-03093-x.
Small vessel childhood primary angiitis of the central nervous system (SV-cPACNS) is a rare disease characterized by inflammation within small vessels such as arterioles or capillaries.
We report a case of SV-cPACNS in an 8-year-old boy confirmed by brain biopsy. This patient was also incidentally found to have anti-glial fibrillary acidic protein (GFAP) antibodies in the cerebrospinal fluid (CSF) but had no evidence of antibody-mediated disease on brain biopsy. A literature review highlighted the rarity of SV-cPACNS and found no prior reports of CSF GFAP-associated SV-cPACNS in the pediatric age group.
We present the first case of biopsy proven SV-cPACNS vasculitis associated with an incidental finding of CSF GFAP antibodies. The GFAP antibodies are likely a clinically insignificant bystander in this case and possibly in other diseases with CNS inflammation. Further research is needed to determine the clinical significance of newer CSF autoantibodies such as anti-GFAP before they are used for medical decision-making in pediatrics.
儿童原发性中枢神经系统小血管血管炎(SV-cPACNS)是一种罕见疾病,其特征是小血管(如小动脉或毛细血管)内发生炎症。
我们报告了一例 8 岁男孩的 SV-cPACNS 病例,该病例经脑活检证实。该患者的脑脊液中还意外发现了抗神经胶质纤维酸性蛋白(GFAP)抗体,但脑活检未发现抗体介导的疾病证据。文献复习强调了 SV-cPACNS 的罕见性,并且在儿科年龄组中没有发现与 CSF GFAP 相关的 SV-cPACNS 的先前报告。
我们提出了首例活检证实的与 CSF GFAP 抗体相关的 SV-cPACNS 血管炎的病例。在这种情况下,GFAP 抗体可能是一种临床意义不大的旁观者,在其他伴有中枢神经系统炎症的疾病中也可能如此。在将新的 CSF 自身抗体(如抗 GFAP 抗体)用于儿科医疗决策之前,需要进一步研究以确定它们的临床意义。